NCT02757339

Brief Summary

This study aims to evaluate the neurobiological basis of traumatic dissociation in a cross-diagnostic sample of women who have histories of childhood abuse and neglect.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Jun 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jun 2015Jun 2026

Study Start

First participant enrolled

June 1, 2015

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 17, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 2, 2016

Completed
10.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

October 27, 2025

Status Verified

October 1, 2025

Enrollment Period

11 years

First QC Date

March 17, 2016

Last Update Submit

October 23, 2025

Conditions

Keywords

neurobiologyPTSDDID

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline correlates of traumatic dissociation in Functional Magnetic Resonance Imaging at 36 to 56 weeks

    Study participation will involve a baseline 60 minute cognitive assessment and a 60 minute Magnetic Resonance Imaging (MRI) at the 3 Tesla magnet in the McLean Hospital Imaging Center focusing on attention, emotion regulation, and symptoms of depersonalization. The first time point is baseline.The second time point will be 36-56 weeks after the baseline 60 minute Magnetic Resonance Imaging (MRI) scan at the 3 Tesla magnet in the McLean Hospital Imaging Center.

    Baseline and 36 to 56 weeks after baseline

Study Arms (2)

Women with History of Childhood Abuse

The study will enroll up to 140 female patients with either DID or PTSD ages 18-89

Healthy Control Group

We will recruit up to 60 control subjects matched for demographics (age, race, gender).

Eligibility Criteria

Age18 Years - 89 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will enroll up to 90 female patients with either DID or PTSD ages 18-89. We will also recruit up to 60 control subjects matched for demographics (age, race, gender).

You may qualify if:

  • Female
  • Clinical diagnosis of PTSD or DID and history of childhood abuse, or healthy controls
  • Age between 18 and 89
  • Legal and mental competency of the patient

You may not qualify if:

  • Male
  • Under 18 or over 89
  • Legal or mental incompetence
  • Delirium secondary to medical illness
  • PTSD or DID due to general medical or neurological illness
  • History of neurological conditions that may cause significant psychiatric symptomatology (e.g., dementia)
  • Any contraindication to MR scans, including claustrophobia, pregnancy, metal implants, etc.
  • Current alcohol or substance dependence or abuse (within the last month)
  • A history of schizophrenia or other psychotic disorder
  • History of head injury or loss of consciousness for longer than 5 min (including concussion)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McLean Hospital

Belmont, Massachusetts, 02478, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Study participants will provide a 2mm saliva sample.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticDissociative Identity Disorder

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersDissociative Disorders

Study Officials

  • Milissa L Kaufman, M.D./Ph.D

    Mclean Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of The Dissociative Disorders and Trauma Research Program

Study Record Dates

First Submitted

March 17, 2016

First Posted

May 2, 2016

Study Start

June 1, 2015

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

October 27, 2025

Record last verified: 2025-10

Locations